Drugs / AZELOPRAZOLE
AZELOPRAZOLE
also known as
Z-215 · Azeloprazol · AZELOPRAZOLE SODIUM · E-3710 FREE BASE · E3710 · Z-215 FREE ACID · Z-215 SODIUM SALT
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT02618629 | Jan → Jun 2016 | — | Zeria Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT02509923 | Jul 2015 → Mar 2016 | — | Zeria Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT01390714 | Jul → Oct 2011 | gastroesophageal reflux disease | Eisai Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02463643 | May 2015 → Oct 2016 | gastroesophageal reflux disease | Zeria Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZELOPRAZOLE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Known as | Azeloprazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Known as | AZELOPRAZOLE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Known as | E-3710 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Known as | E3710 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01390714 ↗ |
| Known as | Z-215 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02463643 ↗ |
| Known as | Z-215 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Known as | Z-215 SODIUM SALT | ChEMBL registry synonym — accepted as the source's own label CHEMBL4300945 ↗ |
| Modality | Small molecule | — CHEMBL4300945 ↗ |
| Route | Oral | “following oral administration to Healthy Male Japanese Subjects” NCT01390714 ↗ |